Thrivent Financial for Lutherans

Position in FTRE — Fortrea Holdings Inc.

CIK 314984 Minneapolis, MN

Position in FTRE

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$1,131,002

-$971,410 QoQ

Shares Held

120,064

-1.5% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. FTRE ranks #31 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	1,568,627	$67,278,411
2	BMRN	Biomarin Pharmaceutical Inc	627,699	$35,458,716
3	VRTX	Vertex Pharmaceuticals Inc / Ma	75,977	$33,926,767
4	RPRX	Royalty Pharma plc	499,167	$23,945,040
5	TECH	BIO-TECHNE Corp	302,934	$15,831,330
6	ARGX	Argenx SE	12,682	$9,261,030
7	ALNY	Alnylam Pharmaceuticals, Inc.	20,470	$6,772,908
8	REGN	Regeneron Pharmaceuticals, Inc.	8,440	$6,521,080

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,131,002	120,064	-1.5%	Shares	Defined	2026-05-01
2025-12-31	$2,102,412	121,879	-22.6%	Shares	Defined	2026-02-05
2025-09-30	$1,325,720	157,449	-31.4%	Shares	Defined	2025-11-04
2025-06-30	$1,133,077	229,368	+88.2%	Shares	Defined	2025-08-26
2025-03-31	$919,937	121,846	-2.8%	Shares	Defined	2025-08-26
2024-12-31	$2,336,732	125,294	+78.1%	Shares	Defined	2025-02-10
2024-09-30	$1,407,240	70,362	-5.2%	Shares	Sole	2024-11-07
2024-06-30	$1,732,178	74,215	-3.7%	Shares	Sole	2024-08-13
2024-03-31	$3,092,225	77,036	-2.6%	Shares	Sole	2024-05-14
2023-12-31	$2,761,567	79,128	-2.4%	Shares	Sole	2024-02-14
2023-09-30	$2,317,248	81,051	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.